Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | depudecin | 47499 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | depudecin | 47499 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | depudecin | 47499 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | depudecin | 47499 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | depudecin | 47499 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | depudecin | 47499 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | depudecin | 47499 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | depudecin | 47499 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | depudecin | 47499 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | depudecin | 47499 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | propofol | 4943 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | propofol | 4943 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | propofol | 4943 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | propofol | 4943 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | propofol | 4943 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | propofol | 4943 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | propofol | 4943 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | IC-86621 | 6843 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | IC-86621 | 6843 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | IC-86621 | 6843 | drug-path |